What is an appropriate ICU care plan for a 53-year-old man readmitted 60 days after subarachnoid hemorrhage, with a history of stroke, peripheral arterial disease, hypertension, type 2 diabetes mellitus, mild pulmonary hypertension, first-degree atrioventricular block, prior small bowel obstruction, and prior ESBL infection, who is currently NPO, afebrile, with blood pressure 159/99 mmHg, heart rate 64 bpm, respiratory rate 13/min, and SpO₂ 100% on room air?

ICU Care Plan for 53-Year-Old Man with Readmission for Subarachnoid Hemorrhage

This 60-day readmission for SAH requires immediate focus on preventing delayed cerebral ischemia (DCI), which is the most likely cause of his readmission and carries significant risk for poor outcomes. 1, 2

Immediate Priorities

Neurological Management

Start enteral nimodipine 60 mg every 4 hours immediately if not already on it—this is the only proven therapy to prevent DCI and improve functional outcomes after SAH 3, 4. Monitor for hypotension given his current BP medications (nicardipine and labetalol), but do not withhold nimodipine as its benefits outweigh risks 5.

• Maintain euvolemia, NOT hypervolemia—prophylactic hypervolemia increases iatrogenic complications without benefit 3, 6
• Institute invasive monitoring (arterial line already likely present; consider ICP monitoring if neurological exam deteriorates) 3
• Perform daily transcranial Doppler (TCD) to detect vasospasm, especially given this is a readmission where DCI is the most common cause (70% of readmissions) 2, 7
• Consider continuous EEG monitoring if mental status changes occur, as clinical exam may be unreliable 8

Blood Pressure Management

Target systolic BP 140-160 mmHg using current nicardipine and labetalol regimen 5. His current BP of 159/99 is acceptable if the aneurysm is secured. Key considerations:

• If DCI develops with clinical symptoms, induce hypertension to SBP 180-200 mmHg while maintaining euvolemia 3, 8
• Avoid excessive BP variability—use continuous infusions rather than boluses
• Labetalol and nicardipine are appropriate agents; α- and β-adrenoreceptor blockers may have better outcomes than other classes 5
• Monitor for cardiac complications (arrhythmias, pulmonary edema) which occur in up to 50% with induced hypertension 5

Cardiovascular Monitoring

Given his first-degree AV block, peripheral arterial disease, and need for vasopressor therapy if DCI develops:

• Continuous telemetry monitoring
• Daily ECG if hypertensive therapy is escalated
• Echocardiography if cardiac output augmentation becomes necessary for DCI treatment 8
• Monitor for stress cardiomyopathy (common in SAH)

Surveillance for Delayed Cerebral Ischemia

DCI typically occurs days 4-14 post-hemorrhage, but this 60-day readmission suggests either recurrent bleeding or late DCI 1, 2. Implement:

• Daily neurological examinations with standardized scales
• TCD every 24-48 hours to detect vasospasm (mean flow velocities >120 cm/s concerning) 7
• CT perfusion or MRI with diffusion-weighted imaging if clinical deterioration occurs 8
• If DCI confirmed: escalate to induced hypertension, consider endovascular balloon angioplasty or intra-arterial vasodilators if refractory 7, 8

Respiratory Management

• Maintain SpO₂ >95% (currently 100% on room air—excellent)
• Avoid hypoxemia and hypercarbia which worsen cerebral perfusion 7
• Given mild pulmonary hypertension history, monitor for pulmonary edema if fluid resuscitation or hypertensive therapy required

Glycemic Control

Target glucose 140-180 mg/dL for his Type 2 diabetes:

• Insulin infusion protocol in ICU setting
• Avoid hypoglycemia which worsens neurological outcomes
• Transition to subcutaneous insulin as clinical status stabilizes

Nutrition

Initiate enteral nutrition within 24-48 hours given NPO status:

• Place nasogastric or nasoduodenal tube
• Start trophic feeds, advance as tolerated
• Given history of small bowel obstruction, monitor for feeding intolerance
• Protein goal 1.2-1.5 g/kg/day for neurological recovery

Infection Prevention

Given ESBL history:

• Contact precautions
• Avoid unnecessary invasive devices
• If fever develops, obtain cultures before empiric antibiotics
• Consider ESBL-active agents (carbapenems) if infection suspected

Medications to AVOID

Do NOT initiate 3, 4:

• Statins (no benefit for DCI prevention)
• Intravenous magnesium (no benefit)
• Tirilazad (no benefit)
• Endothelin receptor antagonists (no benefit)
• Prophylactic antifibrinolytics if aneurysm unsecured (increases ischemic complications)

Readmission Risk Factors Present

This patient has multiple high-risk features for ICU readmission 1, 2:

• History of hypertension (OR 5.3 for readmission)
• This IS a readmission—70% are due to DCI
• Modified Fisher grade likely high given readmission
• Age >60 (older patients readmitted earlier have worse outcomes)

Given these factors, extended ICU monitoring beyond typical 14-day vasospasm window is warranted.

Aneurysm Status Verification

• Confirm aneurysm is secured (coiled or clipped)
• If residual aneurysm present, obtain cerebrovascular imaging to assess for rebleeding as cause of readmission 3
• Maintain SBP <160 mmHg if aneurysm unsecured

Disposition Planning

Do NOT discharge from ICU until:

• Minimum 72 hours without neurological deterioration
• Peak vasospasm window passed (typically day 14, but extended in readmissions)
• Hemodynamic stability without escalating vasopressor requirements
• GCS stable or improving (lower GCS at discharge predicts readmission) 1